Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma

Despite major advances in pediatric cancer research, there has been only modest progress in the survival of children with high risk neuroblastoma (NB) (HRNB). The long term survival rates of HRNB in the United States are still only 30–50%. Due to resistance that often develops during therapy, develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabnis, Nirupama, Pratap, Suraj, Akopova, Irina, Bowman, Paul W., Lacko, Andras G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891009/
https://www.ncbi.nlm.nih.gov/pubmed/24459664
http://dx.doi.org/10.3389/fped.2013.00006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891009/
https://www.ncbi.nlm.nih.gov/pubmed/24459664
http://dx.doi.org/10.3389/fped.2013.00006

Ejemplares similares